Home > Quotes > CERU

Cerulean Pharma Inc. Common Stock Quote & Summary Data

Get CERU Alerts
*Delayed - data as of Apr. 29, 2016 10:54 ET  -  Find a broker to begin trading CERU now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CERU Real Time
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Cerulean Pharma Inc. Common Stock Intraday Chart

Shares Traded

Trading Range

Intraday Last 52 Weeks
High $ 3.5618 $ 6.70
Low $ 3.40 $ 1.82

The current last sale of $3.44 is 89.01% Higher thanthe 52 week low.

P/E Ratio

Company Description (as filed with the SEC)

We are a clinical-stage, oncology-focused company applying our proprietary Dynamic Tumor Targeting(TM) Platform to develop differentiated therapies. We were incorporated under the laws of the State of Delaware on November 28, 2005 under the name Tempo Pharmaceuticals, Inc. In October 2008, we changed our name to Cerulean Pharma Inc. Our Dynamic Tumor Targeting Platform is designed to create nanoparticle-drug conjugates, or NDCs, with the aim of providing safer and more effective therapies for patients living with cancer. NDCs consist of anti-cancer therapeutics, or payloads, covalently linked to a proprietary polymer. An important goal for all drugs is to maximize the net clinical benefit by increasing the desired therapeutic effect while reducing adverse effects. This is especially difficult with drugs used to treat cancer, where the goal is to destroy or inhibit growth of cancer cells without damaging healthy cells.  ... More ...  

Risk Grade

Where does CERU fit in the risk graph?

Risk Grade Scale

Nasdaq Official Price

Consensus Recommendation

Research Brokers before you trade

Want to trade FX?